Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Styrenix Perfor.
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 595 | 485 | 599 | 699 | 653 | 691 | 940 | 944 | 799 | 869 | 826 |
| Expenses + | 512 | 427 | 527 | 609 | 554 | 617 | 852 | 847 | 713 | 828 | 710 |
| Operating Profit | 83 | 58 | 72 | 90 | 99 | 74 | 87 | 96 | 85 | 42 | 116 |
| OPM % | 14% | 12% | 12% | 13% | 15% | 11% | 9% | 10% | 11% | 5% | 14% |
| Other Income + | 3 | 2 | 2 | 2 | 6 | 1 | 3 | 3 | 3 | -1 | 12 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 5 | 5 | 5 |
| Depreciation | 9 | 9 | 9 | 9 | 10 | 10 | 26 | 25 | 26 | 29 | 30 |
| Profit before tax | 76 | 50 | 64 | 82 | 94 | 64 | 61 | 71 | 57 | 6 | 93 |
| Tax % | 26% | 30% | 23% | 26% | 26% | 26% | 10% | 26% | 21% | -155% | 21% |
| Net Profit + | 56 | 35 | 49 | 61 | 70 | 48 | 55 | 52 | 45 | 16 | 73 |
| EPS in Rs | 32.08 | 19.88 | 28.07 | 34.80 | 39.86 | 27.12 | 31.12 | 29.52 | 25.43 | 9.29 | 41.78 |
Financials of Styrenix Perfor.
Annual income statement trend
| Mar 2015 15m | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 2,009 | 2,222 | 2,982 | 3,438 |
| Expenses + | 1,924 | 1,958 | 2,631 | 3,095 |
| Operating Profit | 86 | 264 | 352 | 343 |
| OPM % | 4% | 12% | 12% | 10% |
| Other Income + | 6 | 9 | 12 | 14 |
| Interest | 24 | 4 | 6 | 19 |
| Depreciation | 32 | 37 | 53 | 114 |
| Profit before tax | 36 | 233 | 304 | 223 |
| Tax % | 47% | 26% | 23% | 18% |
| Net Profit + | 19 | 173 | 235 | 183 |
| EPS in Rs | 10.76 | 98.47 | 133.72 | 103.98 |
| Dividend Payout % | 37% | 100% | 23% | 0% |
Financials of Styrenix Perfor.
Capital structure and asset base
| Mar 2015 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 18 | 18 | 18 | 18 |
| Reserves | 469 | 705 | 1,150 | 1,349 |
| Borrowings + | 170 | 27 | 397 | 326 |
| Other Liabilities + | 371 | 288 | 727 | 790 |
| Total Liabilities | 1,028 | 1,038 | 2,291 | 2,483 |
| Fixed Assets + | 288 | 295 | 863 | 962 |
| CWIP | 0 | 28 | 29 | 105 |
| Investments | 0 | 58 | 20 | 97 |
| Other Assets + | 740 | 657 | 1,379 | 1,318 |
| Total Assets | 1,028 | 1,038 | 2,291 | 2,483 |
Financials of Styrenix Perfor.
Operating, investing and financing cash movement
| Mar 2015 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 60 | 216 | 54 | 183 |
| Cash from Investing Activity + | -66 | -88 | -85 | -171 |
| Cash from Financing Activity + | -10 | -177 | 74 | -40 |
| Net Cash Flow | -17 | -48 | 43 | -28 |
| Free Cash Flow | 12 | 178 | -382 | 26 |
| CFO/OP | 86% | 105% | 40% | 77% |
Financials of Styrenix Perfor.
Working capital efficiency and return ratios
| Mar 2015 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 48 | 49 | 54 | 46 |
| Inventory Days | 47 | 60 | 128 | 97 |
| Days Payable | 67 | 50 | 100 | 61 |
| Cash Conversion Cycle | 29 | 58 | 81 | 81 |
| Working Capital Days | 29 | 53 | 72 | 72 |
| ROCE % | 27% | 15% |
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…